Background: Dynamics of infection by Bartonella and Rickettsia species, which are epidemiologically associated in dogs, have not been explored in a controlled setting. Objectives: Describe an outbreak investigation of occult Bartonella spp. infection among a group of dogs, discovered after experimentally induced Rickettsia rickettsii (Rr) infection. Animals: Six apparently healthy purpose-bred Beagles obtained from a commercial vendor.
(SFGR) and Bartonella species. [3] [4] [5] [6] [7] Based on infection of both fleas and ticks with Bartonella spp. and SFGR, it is assumed that the serologic association between these 2 pathogens represents exposure from coinfected vectors or sequential exposure to multiple infected vectors. As the dynamics of Bartonella spp. and SFGR seroreactivity in coexposed dogs have not previously been explored in a controlled setting, it is also possible that infection with Rickettsia rickettsii (Rr) could result in recrudescence of chronic subclinical Bartonella infection.
Vector transmission of different Bartonella species by sand flies, fleas, lice, ticks, and flies is reasonably well documented by laboratory and field studies 8-10 -and transmission by a variety of other vectors has been suspected-but defining a single natural vector for Bartonella transmission among dogs has proved difficult. 1, [9] [10] [11] Nonvectorial routes of transmission of Bartonella spp. are also proposed. Being scratched by an infected, flea-infested cat-allowing inoculation of flea feces under the skin-is a well-known route of transmission for Bartonella henselae (Bh) to humans. Transmission of Bartonella spp. by needle stick and blood transfusion has been reported, demonstrating direct transmission via infected cells, blood, or interstitial fluid in the absence of passage through an arthropod vector. [12] [13] [14] [15] [16] There are also reports implicating transmission by bites or suggesting the possibility of viable Bartonella spp. bacteria in the mouth or saliva. [17] [18] [19] In Korea, Bh DNA was PCR-amplified from over 15% of pet canine saliva samples and almost 30% of toenail samples, 20 and in the United States 5 of 44 Golden Retrievers sampled had Bartonella spp. DNA on oral swabs. 21 Bartonella henselae DNA was found in the saliva of a man with angioedema of the tongue and in his healthy dog, 22 and in eastern China Bartonella exposure was associated with dog bites. 23 However, the extent to which saliva might be infectious has not been established and direct transmission among dogs has not been reported.
Despite the evidence of nonvectorial routes of transmission, in the absence of concurrent flea infestation, the risk of Bartonella transmission is currently considered minimal. 24, 25 However, if transmission can occur directly between dogs-or from dogs to humans in the absence of vectors-this could be of substantial importance.
Establishment of an experimental model of Bartonella spp. infection in non-reservoir hosts has thus far remained elusive, 26 so investigation of the potential for direct transmission of Bartonella spp. has been confined to epidemiologic associations and case reports.
The original study objective was to evaluate sequentially timed serological response to low-dose experimental Rr infection in laboratory-raised dogs. However, after completion of the Rr study, Bh DNA was detected in ear-tip vasculitis lesions in 1 dog. Subsequently, Bartonella spp. antibodies were documented in all dogs, either before or after the experimental Rr infection in a vector-free biocontainment facility. This unexpected circumstance provided an opportunity to investigate both the serologic response to coinfection with these 2 previously associated pathogens, as well as to investigate the potential for reactivation and non-vectorial transmission of Bartonella species. Therefore, the objective of this study was to describe an outbreak investigation of occult Bartonella spp. infection among a group of laboratory-reared dogs subsequent to experimentally induced Rr infection.
| METHODS

| Animals
The animals included in this study were 6 healthy purpose-bred laboratory-reared female Beagles age 6-12 months (to protect their identities, referred to here as Shok, Kat, Tan, Cher, Pam, and Sax). The dogs had received routine preventative care and vaccinations before arrival at the NCSU Laboratory Animal Resources (LAR) facility, including treatment with sulfamethoxazole (30 mg/kg PO daily) and fenbendazole (25 mg/kg PO daily) for 1 week for coccidiosis prior to transport. The dogs were reported by the vendor to be otherwise free from intestinal parasites; Dirofilaria immitis and Brucella canis testing were negative. The vendor's canine housing facility consists of indoor/outdoor concrete-floor runs. The vendor practices routine pest control for the facility environment, but study dogs were not treated with flea/tick preventatives while housed at the vendor. The study was approved by the NCSU Institutional Animal Care and Use Committee (Protocol #16-206).
| Study timeline
The dogs were acquired from a commercial vendor and arrived at the NCSU LAR facility on December 19, 2016 A gross necropsy was permitted for 1 of these 4 dogs (Shok, 11 December, 2017) but histopathology was not performed. One dog (Kat) remains a resident at NCSU LAR at the time of writing (approximately 2.5 years after arrival).
| Study setting
From the date of arrival on December 19, 2017 through April 28, 2017 (the PI and RM phases), all dogs were housed in individual runs with access restricted to LAR personnel and study investigators. Figure 1 shows a housing schematic. The run enclosures had solid concrete 4-ft walls. Metal chain-link fence extended from the wall tops to the ceiling.
The front and back of each run was enclosed with chain-link fence, with front doors opening onto a common corridor run. Dogs were isolated from one another in these separated run enclosures, except during twice daily 5-to 10-minute periods when runs were being cleaned. While runs were cleaned, each dog had access to the common corridor; the fencing between the corridor and each dog's individual run allowed for nose-tonose contact between a dog in the corridor and any other dog.
During the EF phase, dogs were moved to various locations within LAR ( Figure 1B 
| Clinical monitoring
| Diagnostic methods
Serum samples were tested using previously described indirect immunofluorescent antibody (IFA) assays, with results considered seroreactive at titer of 1:64 or greater. 30 Bartonella spp. bacteremia was assessed using enrichment blood culture with the Bartonella alpha proteobacteria growth medium (BAPGM) as previously described. 31 By using standard operating procedures, DNA was extracted from samples intended for Bartonella spp. PCR. 30 Bartonella spp. and strain classification was performed using primers designed to amplify 2 consensus sequences in the Bartonella 16S-23S internal transcribed spacer (ITS) region as described previously with minor modifications. 30, [32] [33] [34] All amplicon products were commercially sequenced (Genewiz, Research Triangle Park, North Carolina) to determine the Bartonella sp. and strain type.
DNA extracted from whole-blood and tissue samples was also used for Rickettsia genus-specific PCR as described previously. 35 
| Diagnostic sampling chronology
The diagnostic testing timeline is shown in Figure 2 . Briefly, blood and serum specimens from all dogs were obtained at prespecified intervals during the PI and RM phases: 4 time points during the PI phase and 3 times weekly for 2 weeks then twice weekly for the subsequent 4 weeks during the RM phase. During the EF phase, samples were obtained at various time points for the dogs remaining in the study, at the discretion of the investigators. During the EF phase, 5 of the 6 dogs remained clinically healthy.
As reported, 36 36 Bartonella henselae DNA was amplified and sequenced, and Bartonella organisms were visualized by laser scanning confocal immunohistochemistry, from the aural margin biopsies. 36 After this diagnosis, the dog was treated with doxycycline 10 mg/kg PO every 12 hours and enrofloxacin 10 mg/kg PO every 24 hours for 6 weeks (August 22, 2017-October 3, 2017). The lesions improved and did not recur after this treatment, and the dog remains clinically healthy at the time of writing (approximately 2 years after onset of ear-tip vasculitis). The number of days post-inoculation that each dog seroconverted based on each immunofluorescent antibody assay antibody is shown. 
| Rickettsia infection
| Bartonella PCR and DNA sequencing
Bartonella PCR on whole blood from all dogs was negative at every time point blood was drawn during all phases ( Figure 2 ). Bartonella alpha-proteobacteria growth medium enrichment PCR on whole blood from all dogs was negative at every point tested ( Figure 2 , Table 2 ).
Bartonella PCR results during the EF phase are summarized in The stored Rr inoculum was tested for Bartonella spp. by PCR:
Bartonella spp. DNA was not amplified from stored inoculum.
| Complete blood count results
Complete blood count results for each dog during the PI and RM phases are shown in Figure 3C Bk antibodies, Bk DNA was not amplified from either tissues or swabs.
We are only able to speculate on the origin of the Bh and putative
Bvb infections. These dogs were either infected before arrival at NCSU LAR or newly infected while residing in the presumed vectorfree housing at the NCSU LAR. If the dogs were infected before arrival at the NCSU, it is possible that the physiologic stress of experimental Rr infection caused reactivation of latent Bartonella infections.
At the vendor's facility, the dogs were housed in indoor/outdoor runs and not treated with flea or tick preventatives, so it is possible that they were exposed during that time. The 3 dogs that were Bartonella spp. seroreactive at the first testing time point (February 10, 2017), and before Rr inoculation, support the possibility of preexisting chronic subclinical infection. The rapid development of Bartonella antibodies (by 9 days after Rr inoculation in 5 of 6 dogs), particularly those dogs that seroconverted to multiple Bartonella spp., also supports reactivation of latent infection. As these dogs had resided at the NCSU LAR for over 7 weeks at the time of this first blood collection, however, it is not possible to determine whether transmission occurred before or after shipment from the vendor. All dogs did receive 1 week of sulfamethoxazole for coccidiosis before shipping, but it is unlikely that would clear Bartonella spp. infections. 37 If the dogs were exposed at the vendor's facility, this highlights the need for researchers to specifically request dogs be treated with flea/tick preventatives and tested for infection prior to research studies, so that coinfection with these vector-borne diseases does not bias the results of their studies.
The possibility of reactivation of latent Bartonella infection in both humans and dogs has been raised in case reports previously.
Bartonella henselae and Epstein-Barr virus were found simultaneously in a man with fever and lymphadenopathy after acute mononucleosis. 38 A dog presumed to have immune-mediated ineffective erythropoiesis was pharmacologically immunosuppressed; his HCT was improving or stable until he had an episode of presumptive kennel cough, at which time his HCT and regenerative response worsened with no change to his immunosuppressive medications. 39 Bartonella henselae was amplified from this dog's blood soon after, and once immunosuppression was discontinued and appropriate antibiotics administered, his ineffective erythropoiesis resolved. Therefore, it is possible that chronic Bh infection reactivated after infectious tracheobronchitis. In a second case, 4 an acutely ill Rr seroreactive dog failed to respond to antibiotic treatment directed against RMSF (doxycycline). When tested 10 days later, the dog had seroconverted to Bh and Bk. Unlike the dogs in this study, this dog developed very high Bh,
Bk, and Rr titers simultaneously, supporting the theory that the dog was exposed to all 3 pathogens on or around the same time. However, it is also possible that that dog was chronically infected with 1 or more Bartonella spp. and experienced reactivation when infected with an SFGR species. Based on these previous reports and the results in this case series, it is likely that dogs can harbor chronic subclinical
Bartonella infections that become recrudescent when exposed to the physiologic stress induced by coinfection.
However, it is instead possible that the dogs reported here were newly infected while residing at the NCSU LAR, which begs the question of transmission route. Because Bartonella species are considered to be primarily vector-borne, the animal housing areas at the NCSU LAR are maintained with strict vector-prevention methods. These dogs were checked daily for ectoparasites: none were reported throughout the duration of the study. Dogs were only allowed outdoor access during the EF phase (by which point all dogs had already seroconverted to Bartonella spp.), and all dogs that were given access to outdoor areas were treated monthly with a topical flea and tick preventative (Frontline Plus for Dogs, Merial Inc, Duluth, Georgia).
There remains the unlikely possibility that a previously unknown vector remained undetected in the LAR facility and was able to facilitate transmission between dogs.
If we remove the possibility for vector transmission, then we must consider the possibility of direct transmission, via the contact allowed by the chain-link fence between individual runs during the PI Our results also highlight the previously reported poor sensitivity of the diagnostic Bartonella spp. IFA, 26, 41, 42 as evidenced by the lack of Bartonella seroreactivity at various time points in dogs with positive tissue PCR (Shok and Kat) or oral swab PCR (Pam). Sensitivity and specificity for the IFAs performed in this study have not been previously explicitly evaluated; however, previous studies using similar IFA protocols have been done. 26, 43, 44 When 20 naturally infected Bh PCR-positive dogs had serology performed (on serum sampled concurrently with the PCR-positive blood samples), only 1 dog was Bh seroreactive for the antigen used in this study (Bh SA2). 43 In 3 dogs experimentally infected with Bh H1 and proven bacteremic, none were seroreactive against Bh SA2 (though all seroconverted to Bh H1). 44 Conversely, a single dog experimentally infected with Bh SA2 seroconverted to Bh SA2 2 weeks after infection and maintained seroreactivity for approximately 6 weeks, after which titers waxed and waned until finally remaining below 1:16 after 12 weeks. 26 The lack of sensitivity of Bartonella IFA overall could be due to immunecomplexing of antibodies, antibodies below the level of detection, relapsing infection, genotype-specific antibody responses, or other asyet undetermined mechanisms. 41, 43 The specificity of IFA is higher than the sensitivity and was recently estimated to be at least 85% for an expanded panel of antigens but could be significantly higher given the previously described level of seroreactivity in the healthy/blood donor dog population. 43, 45 In addition to the poor sensitivity of IFA, there are other limita- With regard to the Rr infection, we showed that the serologic response was consistent with previous experimental studies of RMSF in dogs. 28, 29 Because Rr is an endotheliotropic pathogen infecting predominantly endothelial cells of small-and medium-size blood vessels, low numbers of Rr circulate in peripheral blood of most infected patients. 51, 52 As such, Rickettsia genus-specific PCR using the 23S-5S intergenic region from blood specimens (as was performed in this study) was not expected to be positive in these dogs inoculated with low-dose Rr (although the use of more specific primers or nested PCR can enhance detection). [52] [53] [54] As expected, therefore, Rr DNA was not amplified at any time from these dogs, and IFA seroconversion was Previous studies have shown that after experimental infection, repeat inoculation with Rr elicits no clinical illness, hematological changes, or recall IgM response. 28, 29 Additionally, recrudescent infection with Rr is not thought to occur in dogs or humans. 55 When inoculated with Rr, the 1 dog in this study (Kat) that was Rr seroreactive became clinically ill and had a robust IgM response, making it unlikely that she was previously infected with Rr. Because Rr IFA cross-reacts with multiple SFGR species, this dog likely had exposure to another SFG rickettsia (or a cross-reactive non-Rickettsia species) that did not provide cross-protection to Rr infection.
The major limitation of this study is the lack of sequential, prospective sampling of all dogs, particularly during the EF phase. For several reasons, samples were not obtained at predetermined time intervals after the RM phase. Prospective sampling to assess Bartonella spp. reactivation, transmission, or both possibilities was pursued only after documentation of intra-lesional Bh in the dog with ear-tip vasculitis. 36 Lack of sequential sample collection limits our ability to draw conclusions about when, where, and how the dogs in this study became infected. It is unfortunate that we did not obtain blood and tissue samples from the dogs immediately upon arrival at LAR, allowing us to determine more definitively the timing of infection. Additionally, there are inherent limitations in using IFA and PCR as previously discussed. Interpretation of IFA is subjective, and determining the end point titer is usually known to have a margin of error of 1-fold dilution above or below. This can result in misclassification bias, particularly when the IFA is performed unblinded (as ours were in this study). In few cases where IFA results differed upon repeat testing, we reported the more conservative (lower) titer, to limit the likelihood of false-positives.
Despite limitations, this study supports the possibility of chronic subclinical Bh infection with recrudescence after infection with Rr.
Additionally, the possibility for nonvectorial direct transmission via saliva or other body fluids should be further investigated with controlled experimental studies. Occult infections in research animals could cause spurious conclusions in studies utilizing these animals for infectious disease or other biomedical research. Also, if direct transmission is able to occur for this pathogen that has been considered primarily vector-borne, there are wide-ranging biosafety and zoonotic disease implications of substantial veterinary and human medical importance.
